Business Context and Reporting Period
This Form 8-K reports on a Special Meeting of Stockholders held by Amedica Corporation on November 3, 2015. The filing details the voting results on four proposals regarding capital structure, stock consolidation, and auditor ratification. Note: The request metadata references "Sintx Technologies, Inc.", but the filing text explicitly identifies the registrant as Amedica Corporation.
Key Financial Metrics
This filing is a current report on corporate governance events and does not contain financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes and Voting Results
Stockholders approved four key proposals at the Special Meeting:
- Proposal 1 (Warrant Exercise): Approved the issuance of common stock representing more than 19.99% of outstanding voting power to raise approximately $10 million in gross proceeds via the exercise of Series B, C, and D warrants.
- For: 25,454,872
- Against: 5,270,354
- Abstain: 241,413
- Broker Non-vote: 22,864,933
- Proposal 2 (Reverse Stock Split): Approved an amendment to the Restated Certificate of Incorporation to authorize a reverse stock split at a ratio between 1-for-2 and 1-for-15, at the Board's discretion.
- For: 45,023,229
- Against: 8,519,173
- Abstain: 289,167
- Proposal 3 (Auditor Ratification): Ratified the appointment of Mantyla McReynolds LLC as the independent registered public accounting firm for the year ending December 31, 2015.
- For: 48,706,947
- Against: 3,164,967
- Abstain: 1,959,657
- Proposal 4 (Adjournment): Approved the ability to adjourn the meeting to solicit additional proxies if necessary.
- For: 46,279,863
- Against: 6,645,096
Guidance, Outlook, and Risks
The filing does not provide management commentary on future guidance, outlook, or specific risk factors beyond the standard context of the stockholder vote. The approval of the warrant exercise indicates a strategic move to secure capital, while the reverse stock split authorization suggests an intent to adjust the share price or meet listing requirements.
Investor Verification Checklist
- Verify the exact reverse stock split ratio selected by the Board of Directors, as the filing only authorizes a range (1-for-2 to 1-for-15).
- Confirm the final closing date and actual share issuance count related to the $10 million warrant exercise.
- Review the impact of the significant number of broker non-votes (22.8 million) on the effective voting power for the warrant proposal.
- Check subsequent filings for the official implementation of the reverse stock split and the updated share count.